Skip to main content
OpenTrials
Completed

NCT Number: NCT05428124

Poor In Vitro Fertilisation Outcomes in Genital Tuberculosis - Case Report

This is a case series that highlights the challenges in instituting in vitro fertilisation (IVF) treatment amongs genital tuberculosis patients.

Completed

Looking for future studies?

Notify Me

Key information

About this study

In this case series, the investigators recruited patients undergoing IVF treatment previously diagnosed with TB between 01/01/2014 and 30/06/2021. Patients were recruited at the beginning of their IVF treatments. Total sampling was employed for this study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with confirmed genital tuberculosis enrolling in in vitro fertilisation treatment

Exclusion criteria

  • patients not confirmed to having genital tuberculosis

Treatment and study plan

In vitro fertilisation

Other

In vitro fertilisation

Other names: Assisted reproductive technology

Primary outcomes

  1. Live birth rate

    Time frame: 9 months of gestation

    the number of live births divided by the number of patients recruited

Secondary outcomes

  1. Clinical pregnancy rate

    Time frame: 9 months of gestation

    the number of clinical pregnancies divided by the number of patients recruited

Sponsors and collaborators

Lead sponsor

Universitas Padjadjaran

Other

Registry information

Important dates

Study start
2014
Primary completion
2021
Study completion
2021
First posted
Jun 22, 2022
Registry last updated
Jun 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.